Nutrition Plus Steroids for Immune Therapy Lung Inflammation
Treatments studied
Part of Cancer, Infections, Lungs & breathing clinical trials.
This trial tests whether adding nutritional support to standard steroid treatment helps patients recover from severe lung inflammation caused by immune checkpoint inhibitor cancer drugs. The study aims to improve breathing and overall health in patients who develop this serious side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer confirmed by biopsy or cell testing
- You have received at least one round of immune checkpoint inhibitor therapy (a type of cancer drug)
- You have developed severe immune-related pneumonitis (grade 3-4 lung inflammation from the cancer drug)
- You are between 18 and 75 years old and in generally fair-to-good health (ECOG 0-2)
- Your heart, kidneys, liver, and blood counts are working adequately without recent support medications
- You have not had certain other treatments or conditions that would interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized immune cell therapy for advanced or relapsed lung cancer. Doctors take your blood, create special T cells that target unique proteins on your cancer, and give them back to you to try to fight the tumor.
This study looks for signs in the blood that can tell if a lung cancer patient is developing a side effect called pneumonitis (lung inflammation) from checkpoint inhibitor treatment. It may help doctors catch and treat this side effect early.
This trial tests whether using an inhaled steroid (budesonide) can help prevent lung inflammation (pneumonitis) from coming back in people who have had it caused by immunotherapy cancer treatment. It may be an option for patients who need extra support after their first bout of this side effect.
This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.
This trial tests if taking a probiotic supplement along with your standard lung cancer treatment can help you live longer and respond better to therapy. It is for people with advanced non-small cell lung cancer who have not tried immunotherapy before.
This trial tests whether adding a fiber supplement to standard immunotherapy can help treat advanced non-small cell lung cancer. It's for people whose tumors have high PD-L1 levels and no treatable genetic mutations.
Hear when a new Drug-Related Side Effects and Adverse Reactions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.